Idarubicin‐Loaded DEB‐TACE plus Lenvatinib versus Lenvatinib for patients with advanced hepatocellular carcinoma: A propensity score‐matching analysis.
Saved in:
| Title: | Idarubicin‐Loaded DEB‐TACE plus Lenvatinib versus Lenvatinib for patients with advanced hepatocellular carcinoma: A propensity score‐matching analysis. |
|---|---|
| Authors: | Fan, Wenzhe1 (AUTHOR), Zhu, Bowen1 (AUTHOR), Yue, Shufan2 (AUTHOR), Zheng, Xinlin1 (AUTHOR), Zou, Xinhua1 (AUTHOR), Li, Fuliang3 (AUTHOR), Qiao, Liangliang4 (AUTHOR), Wu, Yanqin1 (AUTHOR), Xue, Miao1 (AUTHOR), Wang, Hongyu1 (AUTHOR), Tang, Yiyang1 (AUTHOR), Li, Jiaping1 (AUTHOR) lijiap@mail.sysu.edu.cn |
| Source: | Cancer Medicine. Jan2023, Vol. 12 Issue 1, p61-72. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
